Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
about
Pharmacology of estrogens and progestogens: influence of different routes of administrationNovel oestrogen sulfamates: a new approach to oral hormone therapy.The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signalingProteome-Wide Effect of 17-β-Estradiol and Lipoxin A4 in an Endometriotic Epithelial Cell LineGender and sex hormones in multiple sclerosis pathology and therapy.Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal SerumGenetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.TRIENNIAL REPRODUCTION SYMPOSIUM: Environmental programming of reproduction during fetal life: Effects of intrauterine position and the endocrine disrupting chemical bisphenol A.Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells.Effects of estriol on cell viability and 1,25-dihydroxyvitamin D3 receptor mRNA expression in cultured human osteoblast-like cells.Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome.Effects of estriol on proliferative activity and expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor mRNA in cultured human osteoblast-like osteosarcoma cells.
P2860
Q28268346-C76E3052-C789-426D-A78E-04CCDBB55DBFQ34430389-962F3586-27E3-4E6B-81A4-7979E4BD8C39Q34880427-78A5D4B6-C778-4A00-9A58-D7D5090867F6Q34932849-1891705A-90EA-42DA-AD2D-F025CE2BD926Q35107985-8ACA0D47-C5DC-43A6-A1A6-F01AEC727560Q36431922-0BAF3A60-07D1-4115-966E-9B58BBCAF3CBQ37209917-78816154-88AF-4DB6-A9C2-646A1832E9BCQ37666802-336581C3-6723-4C50-9E7C-0557A2F52135Q37675831-390FAD9F-E7FA-470D-8819-2BE7028822A5Q38616570-D4C3462A-FD5F-453C-BCFF-16B5CD73BB31Q38915939-0E8B4036-C425-441A-AE11-5649ADB242BCQ40627712-03090D00-C83E-458F-8A08-E7CE0B64BF4BQ44781424-05BD1466-04A4-41B1-9588-02D8C136CFC6Q46092352-D66C0221-1526-4366-B967-5315B0DA32B4Q46558991-2BE5BBA3-0669-4432-AE92-BA40C51713A6
P2860
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@ast
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@en
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@nl
type
label
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@ast
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@en
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@nl
prefLabel
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@ast
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@en
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@nl
P2093
P356
P1476
Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol.
@en
P2093
P304
P356
10.1210/MEND.11.12.0025
P577
1997-11-01T00:00:00Z